Heyman Tomas J. (CIK 1814673) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-29). Recent activity: Buy EXEL (8,367 shares), Sell AKRO (9,398 shares), Buy AKRO (9,398 shares), Buy EXEL (9,812 shares), Sell EXEL (4,544 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | EXELIXIS, INC. (EXEL) | Director | Buy | 8,367 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Director | Sell | 9,398 | $0 |
| 2025-06-05 | Akero Therapeutics, Inc. (AKRO) | Director | Buy | 9,398 | $0 |
| 2025-05-30 | EXELIXIS, INC. (EXEL) | Director | Buy | 9,812 | $0 |
| 2025-05-22 | EXELIXIS, INC. (EXEL) | Director | Sell | 4,544 | $201,254 |
Source: SEC Form 4 filings · as of 2026-05-29